HydroMID Midline Catheter from Access Vascular Receives FDA Clearance
Patented Biomaterial Used in Catheter Designed to Reduce Thrombus Accumulation
Bedford, MA – Feb. 11, 2021- Access Vascular, Inc. today announced FDA clearance of its HydroMIDTM midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has been shown to reduce thrombus accumulation by up to 97 percent when compared to standard polyurethane catheters,1 is the second device in its planned portfolio to obtain clearance.
